Drugs for Neglected Diseases initiative 201d ago

📖 We’re happy to share that Dr Markus Fraundorfer, Associate Professor in Global Governance at the University of Leeds, has published an in-depth study on the impact of our collaborative and not-for-profit drug development model on global health governance: ‘Pharmaceutical Knowledge Commons for the Most Neglected Populations in Global Health’. In this short video, Dr Fraundorfer explains: 🔸what motivated him to write the book 🔸what the key insights from his research are 🔸why the book is especially relevant today for global health 📘 Interested in reading more? 🔗 Get the book with a 30% discount: https://fdslive.oup.com/www.oup.com/academic/pdf/authors/promotion/9780198905295-discount.pdf 🔗 Read the first chapter for free until the end of the month: https://fdslive.oup.com/www.oup.com/academic/pdf/authors/promotion/9780198905295-chapter.pdf 📅 This Friday (14:00–16:00 CET), join the author for an online book launch and panel discussion with experts in global health, access to medicines, infectious diseases, and neglected tropical diseases: Dr Els Torreele, Dr Mady MALHEIROS BARBEITAS, Eric Stobbaerts, Prof Simon Rushton 🔗 Register here: https://events.teams.microsoft.com/event/cb95ad44-dfdd-482f-87c9-0e49c376dec8@bdeaeda8-c81d-45ce-863e-5232a535b7cb/registration ------ The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://dndi.org